Financhill
Sell
33

JANX Quote, Financials, Valuation and Earnings

Last price:
$26.52
Seasonality move :
-9.12%
Day range:
$25.47 - $27.00
52-week range:
$22.48 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
113.17x
P/B ratio:
1.52x
Volume:
581.9K
Avg. volume:
1.1M
1-year change:
-41.26%
Market cap:
$1.5B
Revenue:
$10.6M
EPS (TTM):
-$1.36

Earnings Data

Next earnings date for JANX
Aug 07
2025
Most recent earnings per share
-$0.38
Beat by $0.01
(May 8/2025)
Consensus Estimate
-$0.39
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $300K -- -- -$0.48 --
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.09
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.15
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.24 -$0.39 $0.15
11/07/2023 Q3 -- -- -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- -- -$0.42 -$0.51 $0.09
05/09/2023 Q1 -- -- -$0.42 -$0.47 $0.05
03/10/2023 Q4 -- -- -$0.39 -$0.50 $0.11
11/10/2022 Q3 -- -- -$0.40 -$0.53 $0.13
08/09/2022 Q2 -- -- -$0.41 -$0.39 -$0.02
05/10/2022 Q1 -- -- -$0.32 -- --
03/18/2022 Q4 -- -- -$0.33 -- --
11/09/2021 Q3 -- -- -$0.26 -- --
08/10/2021 Q2 -- -- -$0.62 -- --
03/31/2021 Q1 -- -- -$0.06 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.10 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- -$0.11 -- --

Janux Therapeutics Earnings Questions

  • How Much did Janux Therapeutics Generate in Revenue Last Quarter?

    Janux Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics Beat Earnings Last Quarter?

    Janux Therapeutics announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Janux Therapeutics Profitable?

    Janux Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics EPS Next Year?

    Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -65.09%.

  • When is Janux Therapeutics's Earnings Date?

    Janux Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
64
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
59
SBET alert for Jun 10

SharpLink Gaming [SBET] is up 5.67% over the past day.

Buy
85
ASTS alert for Jun 10

AST SpaceMobile [ASTS] is up 1.44% over the past day.

Buy
69
CCJ alert for Jun 10

Cameco [CCJ] is down 5.04% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock